DCK and acute myeloid leukemia: We analyzed the impact of the polymorphisms of genes encoding cytidine deaminase (CDA A79C) and deoxycytidine kinase (dCK C360G, C201CT) and of in vitro sensitivity to Ara-C on disease outcome and toxicity in 27 de novo pediatric AML patients.